CN1884526A - RNA interference method for specificly and high effectively treating CSFV infection and biological formulation - Google Patents

RNA interference method for specificly and high effectively treating CSFV infection and biological formulation Download PDF

Info

Publication number
CN1884526A
CN1884526A CNA2006100169602A CN200610016960A CN1884526A CN 1884526 A CN1884526 A CN 1884526A CN A2006100169602 A CNA2006100169602 A CN A2006100169602A CN 200610016960 A CN200610016960 A CN 200610016960A CN 1884526 A CN1884526 A CN 1884526A
Authority
CN
China
Prior art keywords
sequence
cell
pestivirus suis
rna
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006100169602A
Other languages
Chinese (zh)
Inventor
涂长春
徐兴然
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Military Veterinary Academy of Military Medical Sciences PLA
Original Assignee
Institute of Military Veterinary Academy of Military Medical Sciences PLA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Military Veterinary Academy of Military Medical Sciences PLA filed Critical Institute of Military Veterinary Academy of Military Medical Sciences PLA
Priority to CNA2006100169602A priority Critical patent/CN1884526A/en
Publication of CN1884526A publication Critical patent/CN1884526A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention provides a specific and high-performance interferometric technique for treating RNA infected by CSFV, which designs specific siRNA sequence for dissimilar genes of hog cholera virus and obtains high-performance and specific interfering RNA molecule for reducing hog cholera virus by T7 RNA polyase external rerecording system and plasmid expression system, so is suitable for commercial manufacture. The biological agent produced by this method has 92.9-99.0% high depression efficiency and can appreciably prevent CSFV affection inside sensitized animals to make the animals relieve from morbidity and death.

Description

A kind of special, efficiently treat RNA interference method and the biotechnological formulation that CSFV infects
Technical field
The invention provides-kind special, efficiently treat the RNA interference method that CSFV infects, the biotechnological formulation that utilizes this method to produce also is provided simultaneously, relate to the medicine for the treatment of swine fever virus infection, belong to biological pharmacy technical field.
Background technology
Write a Chinese character in simplified form CSFV below the Pestivirus suis that the present invention relates to.
At present, in order to prevent the general employing passive immunization (injection hyper-immune serum) and the active immunity method of swine fever virus infection, it is popular still still can not to prevent and treat swine fever fully.
RNA disturbs (RNA interference, RNAi) reported first was in 1998, it is a kind of brand-new technology that just grew up gradually in nearly 2 years, RNAi is considered to the virological investigation field that is used in the lump of the most effectual way of anti-virus infection since the great attention a person that finds to be subjected to the virological investigation.The key of using RNAi technology inhibition virus multiplication is to obtain efficient, the special little RNA of interference (siRNA) sequence.The medicine of using RNA interference method production for treating swine fever virus infection does not by retrieval appear in the newspapers.
Summary of the invention
The invention provides a kind of special, efficiently treat the RNA interference method that CSFV infects, by designing at the heterogeneic special siRNA sequence of Pestivirus suis, utilize T7 RNA polymerase in-vitro transcription system and plasmid expression system, obtain the disturbance RNA molecule of efficient, special inhibition Pestivirus suis, be applicable to suitability for industrialized production.
The present invention also provides the biotechnological formulation that utilizes this side to produce, and up to 92.9-99.0%, can obviously stop the infection of CSFV to the inhibition efficient of CSFV in responsive animal body, makes animal avoid morbidity and dead.
Technical solution of the present invention may further comprise the steps:
1. select the sequence of disturbance RNA molecule effect:
After utilizing the synthetic rnai molecule of RNA perturbation technique design, swine fever virus infection there is obvious therapeutic action thereby these rnai molecules can special, efficiently suppress Pestivirus suis propagation.
Conservative region in the Pestivirus suis genome sequence is according to having AA-N 19The 21nt sequence of feature is carried out homology and secondary structure analysis, selects following 11 the disturbance RNA molecule effect sequences on the Pestivirus suis genome:
Table 1 disturbance RNA molecule effect sequence and position thereof
At gene SiRNA molecule interference sequence The position * Name
Npro AAGGATAGGTAGGGTGACAGG 721-741 N1
Npro AAGAACCCTGAAGTGGATTAG 820-840 N2
C AAGTGGAAGTAAAGAGAAGAA 892-912 S6
E rns AAGAATAAACCACCAGAATCT 1082-1102 S7
E1 AAGGTGGCTTTGTTATTTGAA 2255-2275 S8
NS2-3 AAGATGACTAATGGACTTAGT 3923-3943 S10
NS4A AAGAGGCATATACCAGTAGTCA 7253-7274 S11
NS4B AAGCTGGAATTACAATAATCT 7837-7857 S2
NS5A AAGATGAAGGCAGTTAAGAAT 8606-8626 S3
NS5B AAGAATGAGAAGAGGGACGTC 10700-10720 5B1
3’UTR AAGTTACCACACTACACTCAT 12205-12225 S12
*: the position relatively with reference to strain shimen, GenBank accession number: AF092448.
2. make swine fever treatment biotechnological formulation according to disturbance RNA molecule effect sequence:
Can make by following two kinds of methods
1) external synthetic siRNA molecular biosciences preparation:
According to positive-sense strand and the antisense strand template DNA and the T7 RNA polymerase binding sequence of disturbance RNA molecule effect sequence difference composite coding siRNA molecule, and definite control sequence is the reverse sequence of N1 sequence.
Sequence is as follows:
T7 RNA polymerase binding sequence: GGATCCTAATACGACTCACTATA
5B1 positive-sense strand template sequence: AAGACGTCCCTCTTCTCATTCTATAGTGAGTCGTATTAGGATCC
5B1 antisense strand template sequence: AAGAATGAGAAGAGGGACGTCTATAGTGAGTCGTATTAGGATCC
N1 positive-sense strand template sequence: AACCTGTCACCCTACCTATCCTATAGTGAGTCGTATTAGGATCC
N1 antisense strand template sequence: AAGGATAGGTAGGGTGACAGGTATAGTGAGTCGTATTAGGATCC
N2 positive-sense strand template sequence: AACTAATCCACTTCAGGGTTCTATAGTGAGTCGTATTAGGATCC
N2 antisense strand template sequence: AAGAACCCTGAAGTGGATTAGTATAGTGAGTCGTATTAGGATCC
S6 positive-sense strand template sequence: AATTCTTCTCTTTACTTCCACTATAGTGAGTCGTATTAGGATCC
S6 antisense strand template sequence: AAGTGGAAGTAAAGAGAAGAATATAGTGAGTCGTATTAGGATCC
S7 positive-sense strand template sequence: AAAGATTCTGGTGGTTTATTCTATAGTGAGTCGTATTAGGATCC
S7 antisense strand template sequence: AAGAATAAACCACCAGAATCTTATAGTGAGTCGTATTAGGATCC
S8 positive-sense strand template sequence: AATTCAAATAACAAAGCCACCTATAGTGAGTCGTATTAGGATCC
S8 antisense strand template sequence: AAGGTGGCTTTGTTATTTGAATATAGTGAGTCGTATTAGGATCC
S10 positive-sense strand template sequence: AAACTAAGTCCATTAGTCATCTATAGTGAGTCGTATTAGGATCC
S10 antisense strand template sequence: AAGATGACTAATGGACTTAGTTATAGTGAGTCGTATTAGGATCC
S11 positive-sense strand template sequence: AATGACTACTGGTATATGCCTCTATAGTGAGTCGTATTAGGATCC
S11 antisense strand template sequence: AAGAGGCATATACCAGTAGTCATATAGTGAGTCGTATTAGGATCC
S12 positive-sense strand template sequence: AAATGAGTGTAGTGTGGTAACTATAGTGAGTCGTATTAGGATCC
S12 antisense strand template sequence: AAGTTACCACACTACACTCATTATAGTGAGTCGTATTAGGATCC
S2 positive-sense strand template sequence: AAAGATTATTGTAATTCCAGCTATAGTGAGTCGTATTAGGATCC
S2 antisense strand template sequence: AAGCTGGAATTACAATAATCTTATAGTGAGTCGTATTAGGATCC
S3 positive-sense strand template sequence: AAATTCTTAACTGCCTTCATCTATAGTGAGTCGTATTAGGATCC
S3 antisense strand template sequence: AAGATGAAGGCAGTTAAGAATTATAGTGAGTCGTATTAGGATCC
The positive-sense strand template sequence of contrast: AACCTATCCATCCCACTGTCCTATAGTGAGTCGTATTAGGATCC
The antisense strand template sequence of contrast: AAGGACAGTGGGATGGATAGGTATAGTGAGTCGTATTAGGATCC
It is 100pmol/L that above-mentioned synthetic dna sequence dna is diluted respectively with the water of no DNA enzyme, no RNA enzyme, with PCR method they is synthesized double chain DNA sequence respectively:
The T7 RNA polymerase binding sequence DNA 5.0 μ L that in the PCR pipe of the no DNA enzyme of cleaning, no RNA enzyme, add dilution, the positive-sense strand and the antisence strand dna 5.0 μ L that add above-mentioned siRNA respectively, 10 * dna polymerase buffer liquid, 5.0 μ L, 10mmol/L dNTP 1.0 μ L, water 33.8 μ L, place 95 ℃ of sex change 2min of PCR instrument, add pfu archaeal dna polymerase 0.2 μ L (1U), again in 95 ℃ of sex change 30s, 56 ℃ of annealing 30s, 72 ℃ are extended 10s, after 5 circulations, extend 7min after 72 ℃.After reaction finishes, adding is handled and autoclaved 3mol/L sodium-acetate (pH 5.2) 5.0 μ L through DEPC, the dehydrated alcohol that adds 2.5 times of volumes then, place 10min, the centrifugal 10min of 12000r/min, abandoning supernatant in-20 ℃ behind the mixing, precipitate with 70% washing with alcohol, be deposited in drying at room temperature 10min, add the abundant dissolution precipitation of water 50 μ L of no DNA enzyme, no RNA enzyme, the polyacrylamide gel electrophoresis checks that template DNA prepares the result.
Dubbing method is pressed T7 RiboMAX TMExpress RNAi System specification sheets carries out in-vitro transcription: add the template DNA 4.0 μ L of above-mentioned preparation successively in the PCR pipe of the no DNA enzyme of cleaning, no RNA enzyme, RiboMAX TMExpress T7 2 * damping fluid 10.0 μ L, the water 4.0 μ L of nuclease free, Enzyme Mix, T7 Express 2.0 μ L place 37 ℃ of reaction 1h then; The DNA enzyme 1.0 μ L (1U) that add no RNA enzyme, 37 ℃ of 30min; Mix corresponding siRNA justice and antisense strand transcript, 70 ℃ of insulation 10min slowly are cooled to room temperature; The 3mol/L sodium-acetate (pH 5.2) that adds 1/10 volume, add isopyknic Virahol, ice bath 5min behind the mixing, the centrifugal 10min of 13000r/min, the careful suction removed supernatant liquor, 500 μ L, 70% washing with alcohol precipitation, be deposited in drying at room temperature 10-15min, add the abundant dissolution precipitation of 100 μ L water, electrophoretic examinations is packed as concentration 0.3 μ g/ μ L ,-80 ℃ of preservations behind the mensuration content, the siRNA molecular water solution that obtains the in-vitro transcription generation is swine fever treatment biotechnological formulation, according to the sequence name nominating is respectively: siN1, siN2, siS6, siS7, siS8, siS10, siS11, siS12, siS2, siS3, si5B1, the si contrast.
2) biotechnological formulation of plasmid expression shRNA disturbing molecule:
According to the requirement of pSilencer3.1H1 Hygro (Ambion) shRNA carrier design, be designed for and express shRNA interferential dna sequence dna, layout strategy is seen Fig. 2.In order to improve the efficient that the correct annealing of sequence becomes double chain DNA molecule, be designed to strategy with archaeal dna polymerase synthetic PCR, the dna sequence dna of expressing purpose shRNA sequence is split as the sequence of two sections part complementary pairings, use the VNTI3.0 assistant analysis then, making the complementary pairing base between two sections sequences of fractionation is 21-23bp, be less than 10bp and respectively split sequence self pairing base, to improve the efficient of the synthetic double-stranded template DNA of PCR.
Table 2 synthesizes each shRNA template DNA sequence
Name The template DNA sequence
N1 GACGGATCCGGATAGGTAGGGTGACAGGTTCAAGAGACCTGTC
TGCAAGCTTTTCCAAAAAAGGATAGGTAGGGTGACAGGTCTCTTGAACCTGT
N2 GACGGATCCGAACCCTGAAGTGGATTAGTTCAAGAGACTAATC
TGCAAGCTTTTCCAAAAAAGAACCCTGAAGTGGATTAGTCTCTTGAACTAATC
S6 GGAGGATCCCGTGGAAGTAAAGAGAAGAATTCAAGAGATTCTTC
CCGAAGCTTTTCCAAAAAAGTGGAAGTAAAGAGAAGAATCTCTTGAATTCTTCTC
S7 GGAGGATCCCGAATAAACCACCAGAATCTTTCAAGAGAAGATTC
CCGAAGCTTTTCCAAAAAAGAATAAACCACCAGAATCTTCTCTTGAAAGATTCTG
S8 GGAGGATCCCGGTGGCTTTGTTATTTGAATTCAAGAGATTCAA
CCGAAGCTTTTCCAAAAAAGGTGGCTTTGTTATTTGAATCTCTTGAATTCAAAT
S10 GGAGGATCCCGATGACTAATGGACTTAGTTTCAAGAGAACTAAG
CCGAAGCTTTTCCAAAAAAGATGACTAATGGACTTAGTTCTCTTGAAACTAAGTC
S11 GGAGGATCCCGAGGCATATACCAGTAGTCATTCAAGAGATGACTAC
CCGAAGCTTTTCCAAAAAAGAGGCATATACCAGTAGTCATCTCTTGAATGACTAC
S2 GGAGGATCCCGCTGGAATTACAATAATCTTTCAAGAGAAGATTATTG
CCGAAGCTTTTCCAAAAAAGCTGGAATTACAATAATCTTCTCTTGAAAGATT
S3 GGAGGATCCCGATGAAGGCAGTTAAGAATTTCAAGAGAATTC
CCGAAGCTTTTCCAAAAAAGATGAAGGCAGTTAAGAATTCTCTTGAAATTCTTAAC
5B1 GACGGATCCGAATGAGAAGAGGGACGTCTTCAAGAGAGACGTCC
TCGAAGCTTTTCCAAAAAAGAATGAGAAGAGGGACGTCTCTCTTGAAGACG
S12 GGAGGATCCCGTTACCACACTACACTCATTTCAAGAGAATGAGTG
CCGAAGCTTTTCCAAAAAAGTTACCACACTACACTCATTCTCTTGAAATGAGTG
Contrast GACGGATCCGGACAGTGGGATGGATAGGTTCAAGAGACCTATC
GGCAAGCTTTTCCAAAAAAGGACAGTGGGATGGATAGGTCTCTTGAACCTATCC
Concrete steps are as follows:
With the dilution of synthetic single stranded DNA is 100 μ mol/L, with PCR method they are synthesized double-stranded DNA respectively: get the DNA 5.0 μ L of dilution, add 10 * dna polymerase buffer liquid, 5.0 μ L, 10mmol/L dNTP1.0 μ L, water 33.8 μ L, place 95 ℃ of sex change 2min of PCR instrument, add pfu archaeal dna polymerase 0.2 μ L (1U), again in 95 ℃ of 30s, 56 ℃ of 30s, 72 ℃ of 10s after 5 circulations, extend 7min after 72 ℃.After reaction finishes, add 3mol/L sodium-acetate (pH 5.2) 5.0 μ L, the dehydrated alcohol that adds 2.5 times of volumes is then placed 10min, the centrifugal 10min of 12000r/min in-20 ℃ behind the mixing, abandoning supernatant, with 1000 μ L, 70% washing with alcohol precipitation, abandoning supernatant is deposited in drying at room temperature 10min, add the abundant dissolution precipitation of 50 μ L water ,-80 ℃ of preservations are standby.
The DNA that expresses shRNA with BamHI and HindIII double digestion inserts fragment, enzyme is cut digestion and is finished the back in 70 ℃ of insulation 15min deactivation restriction endonucleases, phenol/chloroform extracting, respectively they are cloned into the BamHI and the HindIII site of pSilencer3.1H1 Hygro carrier behind the ethanol sedimentation, transformed into escherichia coli, carry out PCR Rapid identification with 31H1FP (GTGCTGCAAGGCGATTAAGTTGG) and 31H1RP (GCGGATAACAATTTCACACAGG) for primer to transforming bacterium colony, the PCR positive colony is extracted plasmid in a small amount, the aqueous solution that obtains plasmid is swine fever treatment biotechnological formulation, respectively according to the sequence title with these plasmid called after: shN1, shN2, shS6, shS7, shS8, shS10, shS11, shS12, shS2, shS3, sh5B1, the sh contrast.
Have the effect that suppresses Pestivirus suis propagation by following detection method proof preparation of the present invention:
Example 1
External synthetic siRNA suppresses Pestivirus suis propagation:
1. count the PK-15 cell, with containing the MEM nutritive medium of 10% calf serum, 0.3% glutamine, antibiotic-free with 1.0 * 10 4Go down to posterity in 24 porocyte culture plates in/hole, 37 ℃ of 5%CO 2Cultivate 24h, make attached cell growth full scale be about 30%-50%, inhale and remove nutritive medium, use the MEM nutritive medium of serum-free antibiotic-free to wash monolayer cell 3 times, the MEM that adds 450 μ L serum-free antibiotic-frees is standby.
2. use X-tremeGene siRNA Transfection Reagent (Roche) with synthetic siRNA molecule transfection PK-15 cell, concrete grammar is: respectively at the MEM nutritive medium 47.5 μ L that add the serum-free antibiotic-free in the centrifuge tube of nuclease free, X-tremeGene siRNA Transfection Reagent 2.0 μ L, mixing gently, room temperature leaves standstill 3-5min, get the centrifuge tube of another nuclease free, the MEM nutritive medium 48.0 μ L that add the serum-free antibiotic-free, siRNA molecule 2.0 μ L, mix gently, room temperature leaves standstill 3-5min, mix solution in above-mentioned two centrifuge tubes, room temperature leaves standstill 15-20min, make liposome and siRNA form transfection composite, add respectively then in the PK-15 cell monolayer, gently mixing, hatch 4-6h for 37 ℃, with the MEM of serum-free antibiotic-free washing transfectional cell, use instead contain 2% calf serum the MEM nutritive medium in 37 ℃, 5%CO 2Incubator is cultivated 20h, with 5.0 * 10 2TCID 50The Pestivirus suis Shimen strain cell of siRNA that infected transfection, infect the back and cultivate 72h, with the half cell infection amount (TCID of indirect immunofluorescence assay, Real-time PCR and virus 50) method such as mensuration detects the propagation of Pestivirus suis in transfectional cell, measures the restraining effect of siRNA to viral gene expression in the swine fever virus infection breeding.
Table 1 indirect immunofluorescence assay detects the infected situation result of cell
The siRNA molecule The indirect immunofluorescence result
The si contrast Cell 100% is infected
siN1 Cells infected is less than 1%
siN2 Cells infected is less than 1%
siS2 Cells infected is less than 5%
siS3 Cells infected is less than 5%
siS6 Cells infected is less than 5%
siS7 Cells infected is less than 5%
siS8 Cells infected is less than 5%
siS10 Cells infected is less than 5%
siS11 Cells infected is less than 5%
siS12 Cells infected is less than 5%
si5B1 Cells infected is less than 1%
After the PK-15 cell infection Pestivirus suis of transfection siRNA, the indirect immunofluorescence detected result shows, the PK-15 cell of the PK-15 cell of untransfected and transfection si contrast, behind the pestivirus 72h of infected pigs, nearly all cell all can be by fluorescent antibody staining, and cell sends green fluorescence, after the cell infection Pestivirus suis of the siRNA that the transfection Pestivirus suis is special, have only few cell can be by fluorescent antibody staining, the cell that fluorescence occurs be less than 1% of whole cells.
Table 2Real-time PCR method detects viral genome propagation situation
The siRNA molecule Viral genome propagation behind the infective virus 72h Ratio with contrast
The si contrast 5.95×10 5The total RNA of copies/5ng -
siN1 4.89×10 4The total RNA of copies/5ng 1/12.1
siN2 1.35×10 5The total RNA of copies/5ng 1/4.4
siS2 1.82×10 5The total RNA of copies/5ng 1/3.3
siS3 2.13×10 5The total RNA of copies/5ng 1/2.8
siS6 1.53×10 5The total RNA of copies/5ng 1/3.9
siS7 2.86×10 5The total RNA of copies/5ng 1/2.1
siS8 1.94×10 5The total RNA of copies/5ng 1/3.1
siS10 1.60×10 5The total RNA of copies/5ng 1/3.7
siS11 2.03×10 5The total RNA of copies/5ng 1/2.9
siS12 1.89×10 5The total RNA of copies/5ng 1/3.2
si5B1 1.40×10 5The total RNA of copies/5ng 1/4.2
The result shows: 72h after the cell infection virus of transfection contrast siRNA molecule, the Pestivirus suis geneome RNA copy number in the cell total rna is 5.95 * 10 5The total RNA of copies/5ng, and the Pestivirus suis geneome RNA copy number of siN1, siN2, si5B1, siS2, siS3, siS6, siS7, siS8, siS10, siS11, siS12 transfectional cell is respectively 4.89 * 10 4, 1.35 * 10 5With 1.40 * 10 5, 1.82 * 10 5, 2.13 * 10 5, 1.53 * 10 5, 2.86 * 10 5, 1.94 * 10 5, 1.60 * 10 5, 2.03 * 10 5, 1.89 * 10 5, 1.40 * 10 5The total RNA of copies/5ng, be respectively 1/12.1,1/4.4,1/4.2,1/3.3,1/2.8,1/3.9,1/2.1,1/3.1,1/3.7,1/2.9,1/3.2 of transfection si control cells, the propagation of virus in cells infected that shown siRNA molecules in inhibiting that the Pestivirus suis of transfered cell is special.Reclaim Real-time PCR product, carry out sequencing, the result shows that the Real-time pcr amplified fragment is a Pestivirus suis Shimen strain NS5B gene fragment, illustrates that detected result has the specificity of height.
Table 3 is measured the half cell infection amount (TCID of virus in the cell 50) the increase and decrease situation
The siRNA molecule Infect the TCID of back 60h 50 With contrast ratio
The si contrast 1×10 4.25 -
siN1 1×10 2.58 1/46.8
siN2 1×10 3.08 1/31.6
siS2 1×10 3.11 1/13.8
siS3 1×10 3.20 1/11.2
siS6 1×10 2.91 1/21.9
siS7 1×10 3.26 1/9.8
siS8 1×10 3.13 1/13.2
siS10 1×10 2.97 1/19.1
siS11 1×10 3.14 1/12.9
siS12 1×10 2.99 1/18.2
si5B1 1×10 2.83 1/56.2
The result shows: after the cell infection Pestivirus suis of transfection contrast si contrast, virus can be bred in cell effectively, demonstrates higher infection titer, infects the TCID of back 60h 50Measurement result is 1 * 10 4.25, with 60h behind the non-transfected cells infected pigs pestivirus quite, show that transfection reagent and transfection process pair cell support that the multiplication capacity of Pestivirus suis is effectively less, and after the cell infection Pestivirus suis of transfection Pestivirus suis siRNA molecule, TCID 50Lower, 60h behind the virus infection, the TCID of siN1, siN2, si5B1, siS2, siS3, siS6, siS7, siS8, siS10, siS11, siS12 transfectional cell 50Compare its TCID with the infection titer of si contrast 50Be respectively 1/46.8,1/31.6,1/56.2,1/13.8,1/11.2,1/21.9,1/9.8,1/13.2,1/19.1,1/12.9,1/18.2 times, show that siN1, siN2 and si5B1 siN1, siN2, si5B1, siS2, siS3, siS6, siS7, siS8, siS10, siS11, siS12 have suppressed the propagation of Pestivirus suis effectively.
Example 2.
The shRNA that expresses suppresses Pestivirus suis propagation:
With containing 10% calf serum, not containing antibiotic MEM nutritive medium and go down to posterity the PK-15 cell in 24 porocyte culture plates, every hole 5.0 * 10 4Cell/500 μ L, 37 ℃, 5%CO 2Cultivate 20-24h in the incubator, make cell attachment growth full scale reach 90-95%, use Lipofectamine TM2000 (Invitrogen) carry out transfection, and (every porocyte) method is:
1. get among the MEM that 0.8 μ g plasmid DNA adds 50 μ L serum-free antibiotic-frees mixing.
2. get 2.0 μ L Lipofectamine TM2000 add among the MEM of 50 μ L serum-free antibiotic-frees, and mixing leaves standstill 5min in room temperature gently.
3. the Lipofectamine that the plasmid DNA of dilution is added dilution TMIn 2000, leave standstill 20min in room temperature behind the mixing gently, to form DNA-Lipofectamine TM2000 complex bodys.
4. with the DNA-Lipofectamine that forms TM2000 join above-mentioned preparation in, mixing places 37 ℃ of 5%CO gently 2Transfection 4-6h in the incubator uses instead and contains 2% calf serum and antibiotic MEM, 37 ℃ of 5%CO 2Cultivate standby in the incubator.
5. antibiotics resistance screening
With transfection the cell of shRNA expression plasmid, by optimizing the passage cell full scale of determining, with the MEM that contains 10% serum go down to posterity in 6 porocyte culture plates (the PK-15 cell of the untransfected of the identical full scale that goes down to posterity simultaneously is as the normal control cell of pressurization), after cultivating 24h, use instead and contain the corresponding microbiotic (G-418 or hygromicin B) that kills cell concn, the MEM that contains 2% serum, the cell that does not change plasmid over to is killed in 37 ℃ of cultivations.Use instead every 3d therebetween and contain antibiotic fresh nutrient solution, dead fully until control cells, the cell of transfection plasmid grows cell colony.Use instead and contain the 50% corresponding microbiotic that kills cell concn and continue to cultivate transfectional cell, after cell colony covered with culture hole, enlarged culturing screening gained cell was standby.
6. the shRNA that expresses suppresses the effect detection of Pestivirus suis: the transfectional cell that antibiotics resistance is arranged that screening obtains, go down to posterity in 96 porocyte culture plates with the MEM of antibiotic-free (G-418 or hygromicin B), behind the cultivation 20-24h, with 1 * 10 2TCID 50Pestivirus suis Shimen strain infect, cultivate 72h behind the virus infection, with the half cell infection amount (TCID of indirect immunofluorescence, Real-time PCR, virus 50) method such as mensuration detects the propagation of Pestivirus suis in transfectional cell, measures the restraining effect of siRNA to viral gene expression in the swine fever virus infection breeding.
Table 4 indirect immunofluorescence assay detects the infected situation of cell
Express shRNA molecule plasmid The indirect immunofluorescence result
The sh contrast Cell 100% is infected
shN1 Little fourth 10% cell is infected
shN2 Infected less than 10% cell
shS6 Infected less than 10% cell
shS7 Infected less than 10% cell
shS8 The 30%-60% cell is infected
shS10 The 30%-60% cell is infected
shS11 Infected less than 10% cell
shS2 Infected less than 10% cell
shS3 The 30%-60% cell is infected
sh5B1 Infected less than 10% cell
shS12 The 30%-60% cell is infected
Indirect immunofluorescence assay detects the infected situation result of cell and shows, the shRNA molecules in inhibiting of design virus infected cell.
Table 5Real-time PCR method detects geneome RNA copy number measurement result
Express shRNA molecule plasmid The geneome RNA number Inhibiting rate Suppress multiple
The sh contrast 5.64×10 5 - -
shN1 8.91×10 3 98.4 62.3
shN2 1.28×10 4 97.0 43.1
shS6 1.65×10 4 97.1 33.2
shS7 2.18×10 4 96.3 24.9
shS8 3.40×10 4 94.0 15.6
shS10 5.66×10 3 99.0 98.6
shS11 8.49×10 3 98.5 65.1
shS2 7.54×10 3 98.7 73.8
shS3 1.29×10 4 97.7 42.7
Sh5B1 7.19×10 3 98.7 77.4
shS12 3.99×10 4 92.9 13.1
Annotate: inhibiting rate=(contrast molecule number-shRNA sample molecule number)/contrast molecule number * 100%, calculate each shRNA and suppress the efficient that viral genome is duplicated, suppress the value-1 of multiple in the table for contrast/shRNA.The Real-time PCR method detects geneome RNA copy number measurement result and shows that the genome duplication of Pestivirus suis in transfectional cell has been subjected to suppressing efficiently.
Different time TCID behind the table 6 stable transfected cells infected pigs pestivirus 50Measurement result
Express shRNA molecule plasmid 12h 24h 36h 48h 60h 72h 96h 120h
The Sh contrast 1×10 1.92 1×10 3.67 1×10 1.33 1×10 4.58 1×10 4.58 1×10 4.12 1×10 4.33 1×10 4.08
shN1 1×10 1.17 1×10 1.67 1×10 1.83 1×10 2.58 1×10 2.83 1×10 3.33 1×10 3.58 1×10 3.17
shS6 1×10 1.67 1×10 2.12 1×10 3.08 1×10 3.42 1×10 3.6 1×10 3.92 1×10 3.83 1×10 3.83
shS10 1×10 1.33 1×10 1.92 1×10 2.42 1×10 2.83 1×10 3.17 1×10 3.58 1×10 3.83 1×10 3.12
shS11 1×10 1.58 1×10 2.58 1×10 3.17 1×10 3.12 1×10 3.58 1×10 3.67 1×10 3.92 1×10 3.58
shS2 1×10 1.17 1×10 1.83 1×10 2.12 1×10 2.92 1×10 3.33 1×10 3.67 1×10 3.83 1×10 3.67
shS3 1×10 1.67 1×10 2.12 1×10 2.92 1×10 3.17 1×10 3.58 1×10 3.92 1×10 3.9 1×10 3.83
Sh5B1 1×10 1.08 1×10 1.83 1×10 2.58 1×10 3.08 1×10 3.33 1×10 3.58 1×10 3.67 1×10 3.42
shS12 1×10 1.67 1×10 2.38 1×10 2.92 1×10 3.17 1×10 3.58 1×10 3.67 1×10 3.66 1×10 3.58
shN2 1×10 1.18 1×10 2.34 1×10 2.85 1×10 3.31 1×10 3.54 1×10 3.71 1×10 3.80 1×10 3.65
shS7 1×10 1.21 1×10 2.56 1×10 3.12 1×10 3.68 1×10 3.73 1×10 3.69 1×10 3.78 1×10 3.72
shS8 1×10 1.30 1×10 2.10 1×10 2.04 1×10 3.15 1×10 3.58. 1×10 3.48 1×10 3.68 1×10 3.65
Detected result shows: the cell of transfection sh contrast, behind swine fever virus infection, its infection titer increases rapidly, 48-60h peaks after infection, the variation characteristics of its infection titer when Pestivirus suis is bred have been embodied in the PK-15 cell, and compare with control cells, the cell of the shRNA expression plasmid that the transfection Pestivirus suis is special, the infection titer of Pestivirus suis gathers way slowly, and the infection titer than control cells is much lower, when the infection titer in control cells peaks (48-60h), the infection titer of the cell of the shRNA expression plasmid that the transfection Pestivirus suis is special still remains on lower level, and present comparatively level and smooth rising tendency, the special shRNA of Pestivirus suis that shows plasmid expression makes the assembling process of sophisticated infective virus particle of Pestivirus suis be subjected to inhibition, and restraining effect can continue the long time, even in the highest time of infection titer (72-96h), its infection titer is still compared according to low order of magnitude after the cell infection virus of the shRNA expression plasmid that the transfection Pestivirus suis is special.
Detected result shows, 60h after infection presses sh contrast/shRNA-1 and calculates the inhibition multiple, and then shN1, shS6, shS10, shS11, shS2, shS3, sh5B1, shS12, shN2, shS7, shS8 suppress Pestivirus suis TCID 50Multiple be respectively 56.3,8.2,25.9,10.1,17.9,5.6,17.9,5.6,11.0,6.0,9.0 times, even at shRNA transfectional cell TCID 50Higher 96h still has 4-10 inhibition efficient doubly to virus.
Example 3
The experimentation on animals level
1. buy 50 Japanese white big ear rabbits, be numbered, breeding observing 7d measures rabbit arm's length basis body temperature and measures twice every day, and the rabbit of numbering is carried out random packet with SPSS software, and 8 every group, grouping and injection see Table 3.
The grouping of table 3 experimental rabbit
Group SiRNA (μ g)/only Plasmid (μ g)/only
Si contrast siN1 siN2 sh contrast shN1 shN2 300 300 300 - - - - - - 500 500 500
After the experimental rabbit grouping, by the injected dose shown in the last table, the siRNA and the shRNA expression plasmid of acquisition transcribed in injection respectively, wherein plasmid 24h injection before attacking poison, and the injection site is that neck is subcutaneous, siRNA and attack poison and inject simultaneously is intravenous injection.
2. HCLV attacks poison and body temperature mensuration: the rabbit of injection shRNA expression plasmid and siRNA, and by intravenous injection 50 * ID 50The hog cholera lapinised virus strain, every 12h measures 2 body temperature in the 24h of injection back, every interval 6h measures rabbit body temperature behind the 24h, returns to the normal body temperature value up to rabbit body temperature.
Table 7 respectively organize rabbit mean body temperature (℃)
Time The si contrast siN1 siN2 The sh contrast shN1 shN2
Basal body temperature 0 12 24 30 36 42 48 54 60 66 72 39.2 39.3 39.2 39.3 39.3 39.4 39.8 39.9 40.1 40.4 40.3 40.5 39.9 39.4 39.2 39.4 39.3 39.4 39.2 39.4 39.3 39.6 39.5 39.8 39.9 39.9 39.5 39.4 39.2 39.4 39.3 39.3 39.3 39.2 39.5 39.3 39.5 39.5 39.9 40.0 40.2 39.6 39.3 39.3 39.2 39.2 39.4 39.5 39.6 39.9 39.8 40.2 40.5 40.4 39.8 39.4 39.2 39.2 39.3 39.2 39.4 39.3 39.5 39.5 39.4 39.3 39.7 40.2 39.9 39.4 39.4 39.2 39.3 39.3 39.5 39.4 39.5 39.3 39.5 39.9 40.4 39.9 40.1 39.6
It is as shown in the table, in the siRNA of in-vitro transcription experimental group: in si contrast, siN1 and three groups of siN2,0.5 ℃ the time that the rabbit of the injection si control group of transcribing is heated up first above basal body temperature is at 30h, animal continues to occur high heat afterwards, and can continue 6 temperature time (36h) to attacking poison back 60h, and obviously postponing than control group of fever time appears in experimental group, the time of siN1 group is being attacked poison back 48h, fever time than control group has postponed 12h, and heating has only 3 warm time; The heating time of occurrence of siN2 injection group has postponed 18h attacking poison back 54h than control group, and is same, and its fever time has only continued 18h (3 temperature are inferior), and the mean body temperature of the pyrogenic stage of two groups all is lower than control group.In three experimental group of injection shRNA expression plasmid, the time of the fever in rabbits of injection sh contrast expression plasmid appears at 36h, time length is 36h, and the fever time of experimental group shN1 has postponed 18h at 54h than control group, and the time length is a 18h institute, shN2 injection group the time of heating occurs at 48h, different with other three experimental group is that the heating continuing time of shN2 group is long slightly, is 24h (4 temperature are inferior).
Experimental result from table is found out, the experimental group of the special RNA interfering of injection Pestivirus suis all shows fever time and postpones, the heating medial temperature is more lower slightly than control group, and the characteristics that heating continuing time shortens greatly than control group, show that the special RNA interfering of Pestivirus suis has postponed the hog cholera lapinised virus strain in the intravital propagation of rabbit, postponed making rabbit the required virus quantity of high fever reaction occur.As can be seen, the body temperature rise speed of experimental group is obviously slow than control group in the rabbit body temperature changing trend diagram from Fig. 3, the weak point of the hot time ratio control group of height occurs continuing, and temperature is low than control group.
3. suppressing virus multiplication measures: return to the rabbit of normal body temperature, catch and kill in 6h, aseptic collection rabbit spleen and mesenteric lymph nodes are with the half cell infection amount (TCID of Real-time PCR, virus 50) method such as mensuration detects the propagation of Pestivirus suis in the rabbit body, measures the restraining effect of siRNA molecule to viral gene expression in the swine fever virus infection breeding.
With 50 * ID 50Pestivirus suis rabbitization low virulent strain attack the body temperature that rabbit is measured in poison back, extract the total RNA of rabbit spleen, detect viral genome propagation situation with Real-time PCR, the result shows and sees Table 8.
Table 8 experimental rabbit geneome RNA measurement result
Group Genome copy number ratio (experimental group/control group)
The si contrast - - - - - - - -
siN1 1/13.2 1/2.77 1/4.83 1/8.42 1/9.13 1/1.62 1/4.16 1/17.83
siN2 1/2.37 1/2.93 1/10.07 1/6.2 1/2.43 1/3.02 1/6.04 1/37.57
The sh contrast 1/1.25 1/1.34 1/1.40 1/1.10 1/1.07 1/2.16 1/1.12 1/1.07
shN1 1/3.11 1/1.04 1/7.47 i/30.26 1/6.15 1/1.46 1/6.45 1/3.91
shN2 1/6.54 1/3.21 1/32.37 1/5.02 1/4.72 1/2.04 1.14/1 1/1.97
The genome quantity of control group si contrast and sh contrast fluctuates on higher level, and the genome quantity in the experimental group is then lower, proves that virus multiplication is suppressed.
Get the spleen of respectively organizing experimental rabbit of collection, balanced mix is ground the back and is measured their infection titer, sees Table 9.
Table 9 rabbit spleen inner virus infection titer detected result
Group Rabbit spleen inner virus infection titer
ID 50 Experimental group/contrast
The si contrast 1×10 3.83 -
siN1 1×10 3.08 1/5.62
siN2 1×10 3.33 1/2.15
The sh contrast 1×10 3.92 -
shN1 1×10 3.33 1/3.87
shN2 1×10 3.17 1/5.58
The result shows, the si contrast, and siN1, siN2, the sh contrast, N1, the ID of pairing HCLV is organized in the N2 injection 50Be respectively 1 * 10 3.83, 1 * 10 3.08, 1 * 10 3.33, 1 * 10 3.92, 1 * 10 3.33, 1 * 10 3.17, the ID of control group si contrast 50Be respectively siN1 and siN2 5.62 times and 2.15 times, the ID of sh contrast 50Be respectively N1 and N2 3.87 times and 5.58 times.Measurement result shows that siRNA and shRNA expression plasmid that injection is transcribed have all suppressed the hog cholera lapinised virus strain effectively in the intravital propagation of rabbit.
Positively effect of the present invention is: use the biotechnological formulation of RNA interference method production for treating swine fever virus infection, obtained the disturbance RNA molecule of efficient, special inhibition Pestivirus suis, be applicable to suitability for industrialized production.The present invention also provides the biotechnological formulation that utilizes this side to produce, and up to 92.9-99.0%, can obviously stop the infection of CSFV to the inhibition efficient of CSFV in responsive animal body, makes animal avoid sickness rate and death.
Description of drawings
Fig. 1 is the synthetic siRNA molecular schematic diagram of in-vitro transcription of the present invention.
Fig. 2 is the synoptic diagram of shRNA molecule of the present invention.
Fig. 3 rabbit is attacked the temperature curve behind the poison.
Embodiment
Embodiment 1 siRNA design
Analyze the Pestivirus suis genome sequence of having delivered among the GenBank, select zone conservative in the genome, according to the requirement of RNAi technology, searching has AA-N 19The 21nt sequence of feature, carry out BlastN and secondary structure analysis, according to the BlastN analytical results, with physical and chemical parameters such as their (G+C) % of VNTI3.0 software analysis, Tm value, inner hairpin ring structures, select the lower sequence of (G+C) %, designed 11 siRNA molecule interference sequences at each gene of Pestivirus suis.
Designed sequence and the position in the Pestivirus suis genome thereof are as shown in table 10:
Table 10siRNA molecule interference sequence and position thereof
At gene The siRNA sequence The position * Name
Npro AAGGATAGGTAGGGTGACAGG 721-741 N1
Npro AAGAACCCTGAAGTGGATTAG 820-840 N2
C AAGTGGAAGTAAAGAGAAGAA 892-912 S6
Erns AAGAATAAACCACCAGAATCT 1082-1102 S7
E1 AAGGTGGCTTTGTTATTTGAA 2255-2275 S8
NS2-3 AAGATGACTAATGGACTTAGT 3923-3943 S10
NS4A AAGAGGCATATACCAGTAGTCA 7253-7274 S11
NS4B AAGCTGGAATTACAATAATCT 7837-7857 S2
NS5A AAGATGAAGGCAGTTAAGAAT 8606-8626 S3
NS5B AAGAATGAGAAGAGGGACGTC 10700-10720 5B1
3’UTR AAGTTACCACACTACACTCAT 12205-12225 S12
*: the position relatively with reference to strain shimen, GenBank accession number: AF092448.
Embodiment 2 external synthetic siRNA:
Press T7 RiboMAX TMThe dna sequence dna and the T7 RNA polymerase binding sequence of 11 selected segmental siRNA molecules among the synthetic embodiment 1 of Express RNAi System (Promega) specification sheets design are referring to accompanying drawing 1; Synthesize respectively and transcribe the positive-sense strand of each siRNA molecule and the template DNA of antisense strand, sequence is as follows:
T7 RNA polymerase binding sequence: GGATCCTAATACGACTCACTATA.
5B1 positive-sense strand template sequence: AAGACGTCCCTCTTCTCATTCTATAGTGAGTCGTATTAGGATCC
The template sequence of 5B1 antisense strand: AAGAATGAGAAGAGGGACGTCTATAGTGAGTCGTATTAGGATCC
N1 positive-sense strand template sequence: AACCTGTCACCCTACCTATCCTATAGTGAGTCGTATTAGGATCC
The template sequence of N1 antisense strand: AAGGATAGGTAGGGTGACAGGTATAGTGAGTCGTATTAGGATCC
N2 positive-sense strand template sequence: AACTAATCCACTTCAGGGTTCTATAGTGAGTCGTATTAGGATCC
The template sequence of N2 antisense strand: AAGAACCCTGAAGTGGATTAGTATAGTGAGTCGTATTAGGATCC
S6 positive-sense strand template sequence: AATTCTTCTCTTTACTTCCACTATAGTGAGTCGTATTAGGATCC
The template sequence of S6 antisense strand: AAGTGGAAGTAAAGAGAAGAATATAGTGAGTCGTATTAGGATCC
S7 positive-sense strand template sequence: AAAGATTCTGGTGGTTTATTCTATAGTGAGTCGTATTAGGATCC
The template sequence of S7 antisense strand: AAGAATAAACCACCAGAATCTTATAGTGAGTCGTATTAGGATCC
S8 positive-sense strand template sequence: AATTCAAATAACAAAGCCACCTATAGTGAGTCGTATTAGGATCC
The template sequence of S8 antisense strand: AAGGTGGCTTTGTTATTTGAATATAGTGAGTCGTATTAGGATCC
S10 positive-sense strand template sequence: AAACTAAGTCCATTAGTCATCTATAGTGAGTCGTATTAGGATCC
The template sequence of S10 antisense strand: AAGATGACTAATGGACTTAGTTATAGTGAGTCGTATTAGGATCC
S11 positive-sense strand template sequence: AATGACTACTGGTATATGCCTCTATAGTGAGTCGTATTAGGATCC
The template sequence of S11 antisense strand: AAGAGGCATATACCAGTAGTCATATAGTGAGTCGTATTAGGATCC
S12 positive-sense strand template sequence: AAATGAGTGTAGTGTGGTAACTATAGTGAGTCGTATTAGGATCC
The template sequence of S12 antisense strand: AAGTTACCACACTACACTCATTATAGTGAGTCGTATTAGGATCC
S2 positive-sense strand template sequence: AAAGATTATTGTAATTCCAGCTATAGTGAGTCGTATTAGGATCC
The template sequence of S2 antisense strand: AAGCTGGAATTACAATAATCTTATAGTGAGTCGTATTAGGATCC
S3 positive-sense strand template sequence: AAATTCTTAACTGCCTTCATCTATAGTGAGTCGTATTAGGATCC
The template sequence of S3 antisense strand: AAGATGAAGGCAGTTAAGAATTATAGTGAGTCGTATTAGGATCC
The positive-sense strand template sequence of contrast: AACCTATCCATCCCACTGTCCTATAGTGAGTCGTATTAGGATCC
The template sequence of the antisense strand of contrast: AAGGACAGTGGGATGGATAGGTATAGTGAGTCGTATTAGGATCC
Concrete steps are:
It is 100pmol/L that above-mentioned synthetic DNA is diluted respectively with the water of no DNA enzyme, no RNA enzyme, synthetic respectively by the following step 11 siRNA molecules.
With PCR method they are synthesized double-stranded DNA respectively, no DNA enzyme in cleaning, the T7 RNA polymerase binding sequence DNA 5.0 μ L that add dilution in the PCR pipe of no RNA enzyme, add respectively above-mentioned 11 be used for being transcribed into the siRNA molecule positive-sense strand and antisence strand dna 5.0 μ L, 10 * pfu DNA polymerasebuffer, 5.0 μ L, 10mmol/L dNTP 1.0 μ L, water 33.8 μ L, place 95 ℃ of sex change 2min of PCR instrument, add pfu DNA polymerase 0.2 μ L (1U), again in 95 ℃ of sex change 30s, 56 ℃ of annealing 30s, 72 ℃ are extended 10s, after 5 circulations, extend 7min after 72 ℃.After reaction finishes, adding is handled and autoclaved 3mol/L sodium-acetate (pH 5.2) 5.0 μ L through DEPC, the dehydrated alcohol that adds 2.5 times of volumes then, place 10min, the centrifugal 10min of 12000r/min, abandoning supernatant in-20 ℃ behind the mixing, precipitate with 70% washing with alcohol, be deposited in drying at room temperature 10min, add the abundant dissolution precipitation of water 50 μ L of no DNA enzyme, no RNA enzyme, the polyacrylamide gel electrophoresis checks that template DNA prepares the result.Dubbing method is pressed T7RiboMAX TMExpress RNAi System specification sheets carries out body: add the template DNA 4.0 μ L of above-mentioned preparation successively in the PCR pipe of the no DNA enzyme of cleaning, no RNA enzyme, RiboMAX TMExpress T7 2 * Buffer 10.0 μ L, Nuclease-Free Water 4.0 μ L, Enzyme Mix, T7Express 2.0 μ L place 37 ℃ of reaction 1h then; The DNA enzyme 1.0 μ L (1U) that add no RNA enzyme, 37 ℃ of 30min; Mix corresponding siRNA justice and antisense strand transcript, 70 ℃ of insulation 10min slowly are cooled to room temperature; The 3mol/L sodium-acetate (pH 5.2) that adds 1/10 volume, add isopyknic Virahol, ice bath 5min behind the mixing, the centrifugal 10min of 13000r/min, the careful suction removed supernatant liquor, 500 μ L, 70% washing with alcohol precipitation, be deposited in drying at room temperature 10-15min, add the abundant dissolution precipitation of 100 μ L water, electrophoretic examinations, be packed as 0.3 μ g/ μ L after measuring content ,-80 ℃ of preservations are standby.Obtain external synthetic siRNA swine fever treatment biotechnological formulation, its base sequence sees Table 11.
The external synthetic siRNA of table 11 swine fever treatment biotechnological formulation and contrast siRNA molecule
The siRNA title The biological products base sequence of external synthetic siRNA swine fever treatment
siN1 GGAUAGGUAGGGUGACAGGUU UUCCUAUCCAUCCCACUGUCC
siN2 GAACCCUGAAGUGGAUUAGUU UUCUUGGGACUUCACCUAAUC
siS6 GUGGAAGUAAAGAGAAGAAUU UUCACCUUCAUUUCUCUUCUU
siS7 GAAUAAACCACCAGAAUCUUU UUCUUAUUUGGUGGUCUUAGA
siS8 GGUGGCUUUGUUAUUUGAAUU UUCCACCGAAACAAUAAACUU
siS10 GAUGACUAAUGGACUUAGUUU UUCUACUGAUUACCUGAAUCA
siS11 GAGGCAUAUACCAGUAGUCAUU UUCUCCGUAUAUGGUCAUCAGU
siS2 GCUGGAAUUACAAUAAUCUUU UUCGACCUUAAUGUUAUUAGA
siS3 GAUGAAGGCAGUUAAGAAUUU UUCUACUUCCGUCAAUUCUUA
si5B1 GAAUGAGAAGAGGGACGUCUU UUCUUACUCUUCUCCCUGCAG
siS12 GUUACCACACUACACUCAUUU UUCAAUGGUGUGAUGUGAGUA
The si contrast GGACAGUGGGAUGGAUAGGUU UUCCUGUCACCCUACCUAUCC
The method of design of embodiment 3 plasmid expression shRNA molecules:
According to the requirement of pSilencer3.1H1Hygro (Ambion) shRNA carrier design, be designed for the dna sequence dna of expressing shRNA, layout strategy sees Table 12.In order to improve the efficient that the correct annealing of sequence becomes double chain DNA molecule, be designed to strategy with archaeal dna polymerase synthetic PCR, the dna sequence dna of expressing purpose shRNA sequence is split as the sequence of two sections part complementary pairings, use the VNTI3.0 assistant analysis then, making the complementary pairing base between two sections sequences of fractionation is 21-23bp, be less than 10bp and respectively split sequence self pairing base, to improve the efficient of the synthetic double-stranded template DNA of PCR.
Design synthetic each shRNA template DNA sequence such as table 12:
Table 12 generates the template DNA sequence of shRNA molecule
Name The template DNA sequence
N1 GACGGATCCGGATAGGTAGGGTGACAGGTTCAAGAGACCTGTC
TGCAAGCTTTTCCAAAAAAGGATAGGTAGGGTGACAGGTCTCTTGAACCTGT
N2 GACGGATCCGAACCCTGAAGTGGATTAGTTCAAGAGACTAATC
TGCAAGCTTTTCCAAAAAAGAACCCTGAAGTGGATTAGTCTCTTGAACTAATC
S6 GGAGGATCCCGTGGAAGTAAAGAGAAGAATTCAAGAGATTCTTC
CCGAAGCTTTTCCAAAAAAGTGGAAGTAAAGAGAAGAATCTCTTGAATTCTTCTC
S7 GGAGGATCCCGAATAAACCACCAGAATCTTTCAAGAGAAGATTC
CCGAAGCTTTTCCAAAAAAGAATAAACCACCAGAATCTTCTCTTGAAAGATTCTG
S8 GGAGGATCCCGGTGGCTTTGTTATTTGAATTCAAGAGATTCAA
CCGAAGCTTTTCCAAAAAAGGTGGCTTTGTTATTTGAATCTCTTGAATTCAAAT
S10 GGAGGATCCCGATGACTAATGGACTTAGTTTCAAGAGAACTAAG
CCGAAGCTTTTCCAAAAAAGATGACTAATGGACTTAGTTCTCTTGAAACTAAGTC
S11 GGAGGATCCCGAGGCATATACCAGTAGTCATTCAAGAGATGACTAC
CCGAAGCTTTTCCAAAAAAGAGGCATATACCAGTAGTCATCTCTTGAATGACTAC
S2 GGAGGATCCCGCTGGAATTACAATAATCTTTCAAGAGAAGATTATTG
CCGAAGCTTTTCCAAAAAAGCTGGAATTACAATAATCTTCTCTTGAAAGATT
S3 GGAGGATCCCGATGAAGGCAGTTAAGAATTTCAAGAGAATTC
CCGAAGCTTTTCCAAAAAAGATGAAGGCAGTTAAGAATTCTCTTGAAATTCTTAAC
5B1 GACGGATCCGAATGAGAAGAGGGACGTCTTCAAGAGAGACGTCC
TCGAAGCTTTTCCAAAAAAGAATGAGAAGAGGGACGTCTCTCTTGAAGACG
S12 GGAGGATCCCGTTACCACACTACACTCATTTCAAGAGAATGAGTG
CCGAAGCTTTTCCAAAAAAGTTACCACACTACACTCATTCTCTTGAAATGAGTG
Contrast GACGGATCCGGACAGTGGGATGGATAGGTTCAAGAGACCTATC
GGCAAGCTTTTCCAAAAAAGGACAGTGGGATGGATAGGTCTCTTGAACCTATCC
Concrete steps are as follows:
Synthetic respectively by the following step 11 plasmids that generate the shRNA molecule, with synthetic DNA dilution is 100 μ mol/L, with PCR method they are synthesized double-stranded DNA respectively, method is: the DNA 5.0 μ L that get dilution, add 10 * pfu DNA polymerase buffer, 5.0 μ L, 10mmol/L dNTP 1.0 μ L, water 33.8 μ L, place 95 ℃ of sex change 2min of PCR instrument, add pfu DNA polymerase 0.2 μ L (1U), again in 95 ℃ of 30s, 56 ℃ of 30s, 72 ℃ of 10s after 5 circulations, extend 7min after 72 ℃.After reaction finishes, add 3mol/L sodium-acetate (pH 5.2) 5.0 μ L, the dehydrated alcohol that adds 2.5 times of volumes is then placed 10min, the centrifugal 10min of 12000r/min in-20 ℃ behind the mixing, abandoning supernatant, with 1000 μ L, 70% washing with alcohol precipitation, abandoning supernatant is deposited in drying at room temperature 10min, add the abundant dissolution precipitation of 50 μ L water ,-80 ℃ of preservations are standby.The DNA that expresses shRNA with BamHI and HindIII double digestion inserts fragment, enzyme is cut digestion and is finished the back in 70 ℃ of insulation 15min deactivation restriction endonucleases, phenol/chloroform extracting, respectively they are cloned into the BamHI and the HindIII site of pSilencer3.1H1 Hygro carrier behind the ethanol sedimentation, transformed into escherichia coli, carry out PCR Rapid identification with 31H1FP (GTGCTGCAAGGCGATTAAGTTGG) and 31H1RP (GCGGATAACAATTTCACACAGG) for primer to transforming bacterium colony, the PCR positive colony is extracted plasmid in a small amount, determine the segmental exactness of insertion in the recombinant plasmid by checking order.
The shRNA molecular energy of the plasmid expression that obtains suppresses Pestivirus suis propagation, and the pSilencer3.1H1 Hygro carrier of expressing the shRNA molecule inserts sequence and sees Table 13 between BamHI and HindIII restriction enzyme site.
The pSilencer3.1H1Hygro carrier that table 13 is expressed the shRNA molecule inserts sequence between BamHI and HindIII restriction enzyme site
The shRNA title Sequence base sequence between the BamHI of insertion carrier and HindIII site
shN1 GATCCGGATAGGTAGGGTGACAGGTTCAAGAGACCTGTCACCCTACCTATCCTTTTTTGGAAA GCCTATCCATCCCACTGTCCAAGTTCTCTGGACAGTGGGATGGATAGGAAAAAACCTTTTCGA
shN2 GATCCGAACCCTGAAGTGGATTAGTTCAAGAGACTAATCCACTTCAGGGTTCTTTTTTGGAAA GCTTGGGACTTCACCTAATCAAGTTCTCTGATTAGGTGAAGTCCCAAGAAAAAACCTTTTCGA
shS6 GATCCCGTGGAAGTAAAGAGAAGAATTCAAGAGATTCTTCTCTTTACTTCCACTTTTTTGGAAA GGCACCTTCATTTCTCTTCTTAAGTTCTCTAAGAAGAGAAATGAAGGTGAAAAAACCTTTTCGA
shS7 GATCCCGAATAAACCACCAGAATCTTTCAAGAGAAGATTCTGGTGGTTTATTCTTTTTTGGAAA GGCTTATTTGGTGGTCTTAGAAAGTTCTCTTCTAAGACCACCAAATAAGAAAAAACCTTTTCGA
shS8 GATCCCGGTGGCTTTGTTATTTGAATTCAAGAGATTCAAATAACAAAGCCACCTTTTTTGGAAA GGCCACCGAAACAATAAACTTAAGTTCTCTAAGTTTATTGTTTCGGTGGAAAAAACCTTTTCGA
shS10 GATCCCGATGACTAATGGACTTAGTTTCAAGAGAACTAAGTCCATTAGTCATCTTTTTTGGAAA GGCTACTGATTACCTGAATCAAAGTTCTCTTGATTCAGGTAATCAGTAGAAAAAACCTTTTCGA
shS11 GATCCCGAGGCATATACCAGTAGTCATTCAAGAGATGACTACTGGTATATGCCTCTTTTTTGGAAA GGCTCCGTATATGGTCATCAGTAAGTTCTCTACTGATGACCATATACGGAGAAAAAACCTTTTCGA
shS2 GATCCCGCTGGAATTACAATAATCTTTCAAGAGAAGATTATTGTAATTCCAGCTTTTTTGGAAA GGCGACCTTAATGTTATTAGAAAGTTCTCTTCTAATAACATTAAGGTCGAAAAAACCTTTTCGA
shS3 GATCCCGATGAAGGCAGTTAAGAATTTCAAGAGAATTCTTAACTGCCTTCATCTTTTTTGGAAA GGCTACTTCCGTCAATTCTTAAAGTTCTCTTAAGAATTGACGGAAGTAGAAAAAACCTTTTCGA
sh5B1 GATCCGAATGAGAAGAGGGACGTCTTCAAGAGAGACGTCCCTCTTCTCATTCTTTTTTGGAAA GCTTACTCTTCTCCCTGCAGAAGTTCTCTCTGCAGGGAGAAGAGTAAGAAAAAACCTTTTCGA
shS12 GATCCCGTTACCACACTACACTCATTTCAAGAGAATGAGTGTAGTGTGGTAACTTTTTTGGAAA GGCAATGGTGTGATGTGAGTAAAGTTCTCTTACTCACATCACACCATTGAAAAAACCTTTTCGA
The sh contrast GATCCGGACAGTGGGATGGATAGGTTCAAGAGACCTATCCATCCCACTGTCCTTTTTTGGAAA GCCTGTCACCCTACCTATCCAAGTTCTCTGGATAGGTAGGGTGACAGGAAAAAACCTTTTCGA

Claims (3)

1, sequence on the following Pestivirus suis genome, utilize the synthetic RAN disturbing molecule of RNA perturbation technique design after, thereby these rnai molecules can special, efficiently suppress Pestivirus suis propagation swine fever virus infection is had obvious therapeutic action, it is characterized in that:
AAGGATAGGTAGGGTGACAGG(721-741);
AAGAACCCTGAAGTGGATTAG(820-840);
AAGTGGAAGTAAAGAGAAGAA(892-912);
AAGAATAAACCACCAGAATCT(1082-1102);
AAGGTGGCTTTGTTATTTGAA(2255-2275);
AAGATGACTAATGGACTTAGT(3923-3943);
AAGAGGCATATACCAGTAGTCA(7253-7274);
AAGCTGGAATTACAATAATCT(7837-7857);
AAGATGAAGGCAGTTAAGAAT(8606-8626);
AAGAATGAGAAGAGGGACGTC(10700-10720);
AAGTTACCACACTACACTCAT(12205-12225)。
2, application rights requires the biotechnological formulation method that sequence is made on the 1 described Pestivirus suis genome, may further comprise the steps:
Positive-sense strand and the antisense strand template DNA and the T7 RNA polymerase binding sequence of the siRNA molecule of the synthetic described sequence of claim 1 utilize T7 RiboMAX TMThe siRNA molecule is synthesized in the system design of Express RNAiSystem (Promega) in-vitro transcription, obtains the siRNA molecule swine fever treatment biotechnological formulation that in-vitro transcription generates.
3, application rights requires the biotechnological formulation method that sequence is made on the 1 described Pestivirus suis genome, may further comprise the steps:
According to pSilencer3.1H1 Hygro (Ambion) shRNA carrier using method, the synthetic plasmid that can generate the shRNA molecule at sequence on the Pestivirus suis genome according to claim 1 obtains swine fever treatment biotechnological formulation.
CNA2006100169602A 2006-06-21 2006-06-21 RNA interference method for specificly and high effectively treating CSFV infection and biological formulation Pending CN1884526A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2006100169602A CN1884526A (en) 2006-06-21 2006-06-21 RNA interference method for specificly and high effectively treating CSFV infection and biological formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2006100169602A CN1884526A (en) 2006-06-21 2006-06-21 RNA interference method for specificly and high effectively treating CSFV infection and biological formulation

Publications (1)

Publication Number Publication Date
CN1884526A true CN1884526A (en) 2006-12-27

Family

ID=37582831

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2006100169602A Pending CN1884526A (en) 2006-06-21 2006-06-21 RNA interference method for specificly and high effectively treating CSFV infection and biological formulation

Country Status (1)

Country Link
CN (1) CN1884526A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102154293A (en) * 2011-01-20 2011-08-17 中国人民解放军军事医学科学院军事兽医研究所 Small-interfering RNA (siRNA) capable of inhibiting classical swine fever virus (CSFV) reproduction and infection as well as preparation method and application thereof
CN104059914A (en) * 2014-06-09 2014-09-24 中国农业科学院哈尔滨兽医研究所 Anti-swine fever virus infection siRNA (small interfering ribonucleic acid) and application thereof
CN106957846A (en) * 2017-05-16 2017-07-18 吉林大学 Effectively suppress siRNA and purposes that CSFV is replicated and bred

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102154293A (en) * 2011-01-20 2011-08-17 中国人民解放军军事医学科学院军事兽医研究所 Small-interfering RNA (siRNA) capable of inhibiting classical swine fever virus (CSFV) reproduction and infection as well as preparation method and application thereof
CN102154293B (en) * 2011-01-20 2012-10-03 中国人民解放军军事医学科学院军事兽医研究所 Small-interfering RNA (siRNA) capable of inhibiting classical swine fever virus (CSFV) reproduction and infection as well as preparation method and application thereof
CN104059914A (en) * 2014-06-09 2014-09-24 中国农业科学院哈尔滨兽医研究所 Anti-swine fever virus infection siRNA (small interfering ribonucleic acid) and application thereof
CN105505937A (en) * 2014-06-09 2016-04-20 中国农业科学院哈尔滨兽医研究所 Classic swine fever virus infection resisting siRNA and application thereof
CN105505937B (en) * 2014-06-09 2019-03-01 中国农业科学院哈尔滨兽医研究所 The siRNA of swine fever virus resistant infection and its application
CN106957846A (en) * 2017-05-16 2017-07-18 吉林大学 Effectively suppress siRNA and purposes that CSFV is replicated and bred

Similar Documents

Publication Publication Date Title
CN107828788B (en) Application of lncRNA related to PRRSV infection and siRNA thereof in inhibiting virus replication
CN114561354B (en) Method for improving killing activity of NK (natural killer) cells
CN102154293B (en) Small-interfering RNA (siRNA) capable of inhibiting classical swine fever virus (CSFV) reproduction and infection as well as preparation method and application thereof
CN1884526A (en) RNA interference method for specificly and high effectively treating CSFV infection and biological formulation
CN103667286B (en) The siRNA of Schistosoma japonicum PGMRC2 gene and application thereof
CN111808858B (en) siRNA sequence and application of target thereof in improving PEDV (porcine reproductive and respiratory syndrome Virus) toxicity
CN1793359A (en) HBV specificity interference target point gene and its siRNA and application in anti HBV infecting thereof
CN104830863A (en) siRNA for inhibiting expression of FABP4 gene and application of siRNA
Neerukonda et al. A comparison of exosome purification methods using serum of Marek's disease virus (MDV)-vaccinated and-tumor-bearing chickens
CN1869220A (en) Application of ShRNA pointed at HBV gene in inhibiting hepatitis B virus duplication
CN1283803C (en) Attenuated HSV-1 vector for gene therapy
CN1249243C (en) Targetted liver cancer AFP gene siRNAs expression carrier and its constructing method and use
CN1667120A (en) RNA interfered target sequence of HBV and use thereof
CN1324136C (en) SiRNA double chain for inhibiting bc 1-2 gen expression and use
CN102399785B (en) Preparation method and purpose of immune nucleic acid (iRNA)
CN1781551A (en) Fumor invasion and metastasis resisting function and use of venin cysteine proteinase inhibitor
CN101054591A (en) Oligonucleotide for targeted activation of chronic granulocyte leukaemia protein kinase PKR and application thereof
CN101407809A (en) Specific inference hog cholera virus genome sequence and method for efficiently curing hog cholera virus infection
CN106039302A (en) Porcine reproductive and respiratory syndrome virus nucleic acid vaccine and preparation method thereof
CN1800387A (en) Small interfering RNA for suppressing multiple effect growth factor expression and its uses
CN1880332A (en) siRNA double-chain for suppressing bc1-2 gene expression
CN1880330A (en) siRNA double-chain for suppressing bc1-2 gene expression
CN1795274A (en) Selected rna motifs to include cell death and/or apoptosis
CN1247608C (en) Gene therapeutic drug hdm2-siRNA for breast cancer
CN1274706C (en) Antisense nucleic acid with virus infection inhibiting function

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication